Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription
- PMID: 10866664
- PMCID: PMC85957
- DOI: 10.1128/MCB.20.14.5077-5086.2000
Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription
Abstract
Tat stimulates human immunodeficiency virus type 1 (HIV-1) transcriptional elongation by recruitment of carboxyl-terminal domain (CTD) kinases to the HIV-1 promoter. Using an immobilized DNA template assay, we have analyzed the effect of Tat on kinase activity during the initiation and elongation phases of HIV-1 transcription. Our results demonstrate that cyclin-dependent kinase 7 (CDK7) (TFIIH) and CDK9 (P-TEFb) both associate with the HIV-1 preinitiation complex. Hyperphosphorylation of the RNA polymerase II (RNAP II) CTD in the HIV-1 preinitiation complex, in the absence of Tat, takes place at CTD serine 2 and serine 5. Analysis of preinitiation complexes formed in immunodepleted extracts suggests that CDK9 phosphorylates serine 2, while CDK7 phosphorylates serine 5. Remarkably, in the presence of Tat, the substrate specificity of CDK9 is altered, such that the kinase phosphorylates both serine 2 and serine 5. Tat-induced CTD phosphorylation by CDK9 is strongly inhibited by low concentrations of 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole, an inhibitor of transcription elongation by RNAP II. Analysis of stalled transcription elongation complexes demonstrates that CDK7 is released from the transcription complex between positions +14 and +36, prior to the synthesis of transactivation response (TAR) RNA. In contrast, CDK9 stays associated with the complex through +79. Analysis of CTD phosphorylation indicates a biphasic modification pattern, one in the preinitiation complex and the other between +36 and +79. The second phase of CTD phosphorylation is Tat-dependent and TAR-dependent. These studies suggest that the ability of Tat to increase transcriptional elongation may be due to its ability to modify the substrate specificity of the CDK9 complex.
Figures
![FIG. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/85957/bin/mb1400527001.gif)
![FIG. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/85957/bin/mb1400527002.gif)
![FIG. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/85957/bin/mb1400527003.gif)
![FIG. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/85957/bin/mb1400527004.gif)
![FIG. 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/85957/bin/mb1400527005.gif)
![FIG. 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/85957/bin/mb1400527006.gif)
![FIG. 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/85957/bin/mb1400527007.gif)
![FIG. 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/85957/bin/mb1400527008.gif)
![FIG. 9](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/85957/bin/mb1400527009.gif)
Similar articles
-
Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation.J Mol Biol. 1999 Jul 30;290(5):929-41. doi: 10.1006/jmbi.1999.2933. J Mol Biol. 1999. PMID: 10438593
-
HIV-1 Tat-associated RNA polymerase C-terminal domain kinase, CDK2, phosphorylates CDK7 and stimulates Tat-mediated transcription.Biochem J. 2002 Jun 15;364(Pt 3):649-57. doi: 10.1042/BJ20011191. Biochem J. 2002. PMID: 12049628 Free PMC article.
-
Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation.Mol Cell Biol. 2002 Jul;22(13):4622-37. doi: 10.1128/MCB.22.13.4622-4637.2002. Mol Cell Biol. 2002. PMID: 12052871 Free PMC article.
-
Regulatory functions of Cdk9 and of cyclin T1 in HIV tat transactivation pathway gene expression.J Cell Biochem. 1999 Dec 1;75(3):357-68. J Cell Biochem. 1999. PMID: 10536359 Review.
-
Tackling Tat.J Mol Biol. 1999 Oct 22;293(2):235-54. doi: 10.1006/jmbi.1999.3060. J Mol Biol. 1999. PMID: 10550206 Review.
Cited by
-
Bioinformatics Insights on Viral Gene Expression Transactivation: From HIV-1 to SARS-CoV-2.Int J Mol Sci. 2024 Mar 16;25(6):3378. doi: 10.3390/ijms25063378. Int J Mol Sci. 2024. PMID: 38542351 Free PMC article.
-
HIV-1 Transcription Inhibition Using Small RNA-Binding Molecules.Pharmaceuticals (Basel). 2023 Dec 25;17(1):33. doi: 10.3390/ph17010033. Pharmaceuticals (Basel). 2023. PMID: 38256867 Free PMC article.
-
Catalytic activity of the Bin3/MePCE methyltransferase domain is dispensable for 7SK snRNP function in Drosophila melanogaster.Genetics. 2024 Jan 3;226(1):iyad203. doi: 10.1093/genetics/iyad203. Genetics. 2024. PMID: 37982586
-
Application of the CDK9 inhibitor FIT-039 for the treatment of KSHV-associated malignancy.BMC Cancer. 2023 Jan 20;23(1):71. doi: 10.1186/s12885-023-10540-y. BMC Cancer. 2023. PMID: 36670405 Free PMC article.
-
The Novel Protease Activities of JMJD5-JMJD6-JMJD7 and Arginine Methylation Activities of Arginine Methyltransferases Are Likely Coupled.Biomolecules. 2022 Feb 23;12(3):347. doi: 10.3390/biom12030347. Biomolecules. 2022. PMID: 35327545 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous